ABX & Chemo
Antimicrobials & Chemotherapeutic Drugs
Objectives
- Differentiate patient-related and institution-related surgical infection risk factors.
- Describe the SCIP measures related to the prevention of surgical site infection.
- Discuss the signs and symptoms of anaphylaxis with the appropriate treatment.
- Describe antimicrobial key considerations for special populations such as pregnancy and the elderly.
- Differentiate pharmacological and perioperative considerations for commonly administered antimicrobials.
- Compare and contrast commonly utilized topical antiseptics.
- Differentiate drug classifications, mechanism of action, and adverse effects of commonly administered chemotherapeutic agents.
Antimicrobials
Patient-Related Surgical Infection Risk Factors
- Extremes in age – Young children and the elderly have higher infection risks.
- Poor nutritional status – Address malnutrition to enhance recovery and decrease infection risk.
- Obesity – Increased tissue perfusion disruptions can lead to infections.
- Diabetes mellitus – Impaired immune response increases risk of infections.
- Glucose control – Poor glycemic control is associated with increased surgical site infections (SSIs).
- Tobacco use – Smoking can compromise wound healing and immune function.
- Coexisting infections – Patients with ongoing infections are at greater risk.
- Peripheral vascular disease – Impaired blood flow can hinder healing and increase infection risk.
- Altered immune response – Patients with immunosuppression may be at higher risk for infection.
- Corticosteroid therapy – Suppresses the immune response, increasing SSI risk.
- Preoperative skin prep – Proper preparation can significantly reduce infection rates.
- Length of preoperative stay – Longer stays may correlate with higher infection risk.
Institution-Related Surgical Infection Risk Factors
- Surgical experience – An experienced surgical team can reduce infection risk.
- Surgical approach (e.g., open vs laparoscopic) – More invasive methods may have higher infection rates.
- Duration of procedure – Longer surgeries increase infection risk.
- Hospital environment and sterilization – Proper sterilization techniques are essential for infection prevention.
- Maintenance of perioperative normothermia – Hypothermia during surgery increases infection risks.
Prophylaxis for Surgery
- Timing – Recommended administration should be within 1 hour prior to surgical incision.
- Short-acting agents may require intraoperative redosing for efficiency.
- Duration of administration – Antimicrobials should not be given for more than 24 hours post-surgery.
- Antibiotic specificity – The choice of antibiotic should be tailored to the surgical procedure type.
- Cephalosporins are commonly used, exemplified by cefazolin.
- Anaphylaxis to cephalosporins is rare, and cross-reactivity with penicillin allergy is about 1%.
Recommended Doses and Redosing Intervals for Commonly Used Antimicrobials for Surgical Prophylaxis
- Cefazolin:
- Recommended Dose: 2 g (3 g for patients weighing ≥120kg)
- Pediatrics: 30 mg/kg
- Elimination Half-life: 1.2-2.2 hours
- Recommended Redosing Interval: 4 hours
- Cefoxitin:
- Recommended Dose: 2 g
- Pediatrics: 40 mg/kg
- Elimination Half-life: 0.7-1.1 hours
- Recommended Redosing Interval: 2 hours
- Clindamycin:
- Recommended Dose: 900 mg
- Pediatrics: 10 mg/kg
- Elimination Half-life: 2-4 hours
- Recommended Redosing Interval: 9 hours
- Gentamicin:
- Recommended Dose: 5 mg/kg based on dosing weight (single dose)
- Piperacillin-tazobactam:
- Recommended Dose: 3.375 g
- Pediatrics: 2.5 mg/kg based on dosing weight
- Elimination Half-life: 0.7-1.2 hours
- Recommended Redosing Interval: 2 hours
- Vancomycin:
- Recommended Dose: 15 mg/kg
- Infants 2-9 months: 80 mg/kg of the piperacillin component
- Children >9 months and ≤40 kg: 100 mg/kg of the piperacillin component
- Elimination Half-life: 4-8 hours
- Recommended Redosing Interval: N/A
Antimicrobial Associated Drug Toxicity
- Allergic reactions: can occur with all antimicrobials, but are more frequent with B-lactam derivatives.
- Nephrotoxicity: often linked to aminoglycosides and polymyxins.
- Ototoxicity: particularly noted with aminoglycosides and vancomycin (auditory neurotoxicity).
- Seizures: may be caused by penicillins and metronidazole in certain patients.
- Neuromuscular blockade: associated to aminoglycosides and metronidazole.
- Teratogenicity: Concern for certain groups of antimicrobials, especially regarding pregnancy.
- Tendinitis: attributed to fluoroquinolones.
Anaphylaxis
- Timing – Usually occurs 30-60 minutes post-dosing.
- Signs & Symptoms:
- Urticaria (hives)
- Bronchospasm (tightness of the chest or difficulty in breathing)
- Hemodynamic instability (drop in blood pressure)
- Treatment:
- Administer epinephrine.
- Administer histamine blockers (H1 & H2 blockers).
- Consider steroids for more severe reactions.
Nosocomial Infections
- Common types include:
- Urinary tract infections
- Respiratory tract infections
- Bloodstream infections
- Associated with devices:
- Vascular access catheters
- Ventilators
- Urinary catheters
- Common organisms involved include:
- S. aureus
- S. epidermidis
- Initial therapy frequently involves vancomycin.
Special Considerations: Parturients (Pregnant Women)
- Transfer through placenta: Most antimicrobials can pass from mother to fetus.
- Risks include:
- Pregnancy-related metabolic changes affecting drug efficacy and toxicity.
- Concerns with teratogenicity particularly during early pregnancy (first trimester).
- Delayed gastric emptying can diminish oral absorption.
- Physiological changes that impact drugs include:
- Increased maternal blood volume, GFR, and hepatic metabolism may reduce plasma antimicrobial concentrations.
Antimicrobials in Pregnancy
- Penicillins:
- Maternal Toxicity: Allergic reactions
- Fetal Toxicity: None known
- Excreted in colostrum: Trace
- Cephalosporins:
- Maternal Toxicity: Allergic reactions
- Fetal Toxicity: None known
- Excreted in colostrum: Trace
- Aminoglycosides:
- Maternal Toxicity: Ototoxicity
- Fetal Toxicity: Ototoxicity
- Excreted in colostrum: Yes
- Clindamycin:
- Maternal Toxicity: Allergic reactions
- Fetal Toxicity: None known
- Excreted in colostrum: Trace
- Sulfonamides:
- Maternal Toxicity: Allergic reactions
- Fetal Toxicity: Kernicterus (at term)
- Excreted in colostrum: Yes
Key Considerations for Elderly Patients
- Altered Pharmacokinetics:
- Altered PO Absorption: Decreased gastric acidity and gastrointestinal motility.
- Altered Distribution: Increased total body fat and decreased plasma albumin can affect drug distribution.
- Altered Metabolism: Reduced hepatic blood flow can hinder drug metabolism.
- Altered Excretion: Lower GFR can impact renal clearance of medications.
Penicillins
- Basic structure: Dicyclic nucleus consisting of thiazolidine ring + β-lactam ring.
- Mechanism of Action (MOA):
- Interferes with peptidoglycan synthesis, decreasing the availability of an inhibitor of murein hydrolase.
- Resistance Mechanism: Bacterial production of β-lactamase, which hydrolyzes the β-lactam ring, rendering penicillin ineffective.
- Clinical Indications: Effective for pneumococcal, streptococcal, and meningococcal infections.
Adverse Effects of Penicillins
- Neurotoxicity: High-dose penicillin G IV in end-stage renal disease (ESRD) can lead to hyperkalemia.
- Seizures and Arachnoiditis: Associated with intrathecal administration.
- Excretion:
- Plasma concentration decreases by 50% within 1 hour post-administration.
- 10% is cleared by GFR; 90% through renal tubular secretion.
- Duration of Action Considerations: Anuria can increase the elimination half-time of penicillin G by 10x.
- Probenecid can extend the half-life by blocking renal tubular secretion.
Cephalosporins
- MOA: Bactericidal by inhibiting cell wall synthesis.
- Resistance Mechanism: Similar to penicillins, bacterial production of β-lactamase hydrolyzes the β-lactam ring.
- Allergic Reactions: Occur in 1-10% of patients, mostly with cutaneous manifestations. Anaphylaxis occurs in an estimated ~0.02%.
- Cross-reactivity with Penicillins: Rare, though cephalosporins and penicillins share a β-lactam ring.
Aminoglycosides (e.g., Gentamicin)
- Indications: Bactericidal primarily against gram-negative bacteria.
- Elimination: Mostly occurs through glomerular filtration; increased elimination half-life seen in renal dysfunction.
- Side Effects:
- Ototoxicity: Can lead to vestibular and/or auditory dysfunction.
- Vestibular symptoms: nystagmus, vertigo, nausea, Meniere’s syndrome.
- Auditory symptoms: tinnitus, pressure in ears, potential for deafness.
- Nephrotoxicity: Resulting from accumulation in renal cortex leading to acute tubular necrosis.
- Signs: inability to concentrate urine, proteinuria.
- Skeletal Muscle Weakness: Connected to inhibition of calcium-mediated release of prejunctional Ach.
- Risk Factors: Myasthenia gravis and prolonged drug exposure.
- Treatment: Use of intravenous calcium to mitigate symptoms.
Lincosamides (e.g., Clindamycin)
- MOA: Bactericidal against most gram-positive bacteria.
- Side Effects:
- Gastrointestinal intolerance and risk of pseudomembranous colitis.
- Large doses can cause profound and long-lasting neuromuscular blockade due to decreased Ach release, not easily countered by calcium or anticholinesterase agents.
Vancomycin
- MOA: Bactericidal glycopeptide, impairs gram-positive cell wall synthesis.
- Indications: Treatment of severe staphylococcal infections (e.g., MRSA), enterococcal endocarditis, and in patients allergic to penicillins or cephalosporins.
- Dosage: 10-15 mg/kg infused over 60 minutes; can be initiated 2 hours prior to surgery for prophylactic purposes.
- Elimination: Primarily renal, prolonged in cases of renal failure.
- Target Plasma Levels: Aim for 20-30 mcg/mL for efficacy.
Side Effects of Vancomycin
- Anaphylaxis: Monitor for severe allergic responses.
- Rapid Infusion Side Effects (
Topical Antiseptics
Alcohols
- 70% ethyl alcohol: Effective in killing 90% of bacteria within 2 minutes.
- Primarily reduces bacterial contamination; not effective against fungi or viruses.
- Precautions: Highly flammable until evaporated; avoid pooling (e.g., at umbilicus) and do not drape until dry.
Chlorhexidine
- Mechanism: Disrupts cell membranes of both gram-positive and gram-negative bacteria.
- Usage: Provides continued antibacterial protection on the skin; commonly used for surgical scrubs and patient skin prep.
- Caution: Not suitable for use in the eye or middle ear due to the alcohol base; potential for neurotoxicity.
Povidone-iodine (Betadine)
- Action: Works effectively on bacteria, viruses, and spores.
- Common Uses: Employed for surgical scrubs and skin preparation preoperatively.
- Toxicity: Less toxic to the cornea compared to other antiseptics; rare iodine allergy can occur.
Chemotherapeutic Drugs
Cancer Overview
- Impact: Second leading cause of death in the U.S., following heart disease.
- Statistics: Approximately 38% of individuals will receive a cancer diagnosis; about 42% of cases may be preventable.
- Pathophysiology: Uncontrolled cell division can decimate bodily functions; metastasis is the most clinically relevant factor.
Cancer Diagnosis & Treatment Options
- Traditional Treatments:
- Surgery
- Radiation therapy
- Chemotherapy
- Cancer Genotyping: Identifies genetic abnormalities related to cancer; it is crucial for diagnosis, prognosis, and sometimes treatment strategies.
Common Chemotherapeutic Side Effects
- Myelosuppression leading to:
- Leukopenia
- Thrombocytopenia
- Anemia
- Nausea/Vomiting/Diarrhea: Frequent side effects accompanied by electrolyte disturbances and decreased fluid volume.
- Mucosal ulceration: Can severely affect quality of life.
- Dermatitis and Alopecia: Skin and hair loss as common side effects in various therapies.
Classification of Chemotherapy Drugs
Drug Classes & Their Mechanisms
- Alkylating agents:
- Mechanism: Form covalent bonds with key molecules, damaging proteins, DNA, and RNA.
- Examples: Cisplatin, carboplatin, chlorambucil, cyclophosphamide, ifosfamide.
- Antimetabolites:
- Mechanism: Structural analogs of naturally occurring metabolites involved in nucleic acid synthesis; either substitute for or compete with nucleotides.
- Examples: 5-Fluorouracil, methotrexate, pemetrexed, mercaptopurine, gemcitabine.
- Antitumor antibiotics:
- Mechanism: Intercalate DNA and create free radicals causing strand breaks, critical in disrupting replication.
- Examples: Bleomycin, anthracyclines (doxorubicin, epirubicin).
- Topoisomerase inhibitors:
- Mechanism: Control the 3-D structure of DNA and are responsible for unwinding DNA during replication.
- Examples: Topoisomerase I - irinotecan, topotecan; Topoisomerase II - etoposide.
- Tubulin-binding drugs:
- Mechanism: Affect the mitotic spindle and cell shape/function by preventing microtubule formation/disassembly.
- Examples: Vinca alkaloids (vincristine, vinorelbine), taxoids (docetaxel, paclitaxel).
- Signal transduction modifiers:
- Mechanism: Disrupt growth factor receptor interactions leading to unchecked cell division.
- Examples: Hormonal treatments like antiestrogens (tamoxifen) and antiandrogens (flutamide).
Chemotherapeutic Uses & Side Effects
Common Chemotherapeutic Agents
Alkylating agents (Cyclophosphamide, Cisplatin):
- Therapeutic Uses: Treats a variety of leukemias, lymphomas, myeloma, solid tumors.
- Common Side Effects: Myelosuppression, mucositis, alopecia, seizures, renal failure.
Antimetabolites (Methotrexate, Fluorouracil):
- Therapeutic Uses: Used for cancers such as breast, lung, and lymphomas.
- Common Side Effects: Myelosuppression, mucositis, potential pneumonitis.
Antitumor antibiotics (Bleomycin, Doxorubicin):
- Therapeutic Uses: Hodgkin’s disease, testicular cancer, etc.
- Common Side Effects: Pulmonary fibrosis (bleomycin), cardiomyopathy (doxorubicin), allergic reactions.
Topoisomerase inhibitors (e.g., Irinotecan, Etoposide):
- Therapeutic Uses: Effective against various solid tumors and leukemias.
- Common Side Effects: Myelosuppression, risk of fribrosis, and allergic reactions.
Tubulin-binding drugs (Vincristine, Vinblastine):
- Therapeutic Uses: Effective in lymphomas and small cell lung cancer.
- Common Side Effects: Peripheral neuropathy, myelosuppression.
References
- Pan, S. J., & Flood, P. (2022). Antimicrobials, antiseptics, disinfectants, and management of perioperative infection. In Flood, P. & Rathmell, J. P. (Eds.), Stoelting’s Pharmacology & Physiology in Anesthetic Practice, 6th ed. Philadelphia, PA: Wolters Kluwer Health.
- Kristijansdottir, K., Bodenstine, T. M., & Noronha, S. (2021). Neoplasia. In N. C. Tkacs, L. L. Herrmann, & R. L. Johnson (Eds.), Advanced physiology and pathophysiology, pp. 215-240. Springer.
- Patel, A. K., Urman, R. D., & Rathmell, J. P. (2022). Chemotherapeutic drugs. In Flood, P. & Rathmell, J. P. (Eds.), Stoelting’s Pharmacology & Physiology in Anesthetic Practice, 6th ed. Philadelphia, PA: Wolters Kluwer Health.